Read more about Am2P here
The role of the patient in pharmacovigilance is key. The need for early involvement of the patient in the cycle of drug development is widely recognised, and direct patient reporting of ADRs is encouraged at many levels. This is very important as there are many barriers to safe medicine use, which lead to poor adherence, […]
ISoP decided to develop infographics because we are aware of the difficulties experienced with obtaining and using medicines safely during the COVID-19 pandemic.These infographics are aimed at patients and caregivers. Feel free to display them in hospitals, clinics, pharmacies and any other public spaces appropriate to where medicines are obtained in your country.
All ISoP Memberships include complimentary access to our live Webinars along with an archive of recordings for previous events.
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.
The CIOMS annual award of $1500 US for the best scientific article published in the areas of pharmacovigilance and research ethics is available to medical students. The article must have been published in a scientific peer reviewed journal in English.